We are live on ! Find out more
OMGA

Omega Therapeutics, Inc. Common Stock
OMGA

Delisted

OMGA was delisted on the 24th of February, 2025.

Back to rankings

4 hedge funds and large institutions have $2.5K invested in Omega Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% less funds holding

Funds holding: 53 → 4 (-49)

100% less capital invested

Capital invested by funds: $35.3M → $2.5K (-$35.3M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 49

Holders
4
Holders Change
-49
Holders Change %
-92.45%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
49
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
FP
Flagship Pioneering
Massachusetts
-$21.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.42M
3
HP
Harbourvest Partners
Massachusetts
-$2.62M
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$1.38M
5
SL
Siren LLC
Connecticut
-$987K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
1
Barclays
United Kingdom
$1.08K – – –
PS
2
Principal Securities
Iowa
$1.02K – – –
SPIA
3
Steward Partners Investment Advisory
New York
$405 – – –
FP
4
Flagship Pioneering
Massachusetts
– -$21.8M -29,225,579 Closed
Fidelity Investments
5
Fidelity Investments
Massachusetts
– -$4.42M -5,924,846 Closed
HP
6
Harbourvest Partners
Massachusetts
– -$2.62M -3,512,110 Closed
State of Wisconsin Investment Board
7
State of Wisconsin Investment Board
Wisconsin
– -$1.38M -1,857,265 Closed
SL
8
Siren LLC
Connecticut
– -$987K -1,323,530 Closed
Vanguard Group
9
Vanguard Group
Pennsylvania
– -$818K -1,097,106 Closed
BOCH
10
Blue Owl Capital Holdings
New York
– -$787K -1,055,882 Closed
6CM
11
683 Capital Management
New York
– -$447K -600,000 Closed
Millennium Management
12
Millennium Management
New York
– -$388K -520,898 Closed
7IH
13
72 Investment Holdings
Connecticut
– -$263K -352,941 Closed
BlackRock
14
BlackRock
New York
– -$203K -272,051 Closed
Geode Capital Management
15
Geode Capital Management
Massachusetts
– -$172K -230,833 Closed
SOMRS
16
State of Michigan Retirement System
Michigan
– -$167K -224,117 Closed
UBS Group
17
UBS Group
Switzerland
– -$122K -163,904 Closed
WP
18
Woodline Partners
California
– -$91.1K -122,191 Closed
Point72 Asset Management
19
Point72 Asset Management
Connecticut
– -$86.5K -116,009 Closed
State Street
20
State Street
Massachusetts
– -$70.6K -94,730 Closed
LCAM
21
Long Corridor Asset Management
Hong Kong
– -$63.4K -85,000 Closed
BCM
22
Bridgeway Capital Management
Texas
– -$47.7K -64,000 Closed
RC
23
RBF Capital
California
– -$47.6K -63,857 Closed
GAA
24
Green Alpha Advisors
Colorado
– -$35.5K -47,647 Closed
Northern Trust
25
Northern Trust
Illinois
– -$29.6K -39,706 Closed
1
2

OMGA Hedge Fund Activity: Q1 2025 in Review

4 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q1 2025, worth a combined $2.5K — down 100% from $35.3M a quarter earlier.

Sellers outnumbered buyers: 49 funds closed out of OMGA and 0 opened new positions — a net loss of 49 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Flagship Pioneering, exiting entirely with an estimated $21.8M sold.

  • 4 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q1 2025, down from 53 in Q4 2024.
  • Funds reported $2.5K of Omega Therapeutics, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q1 2025 and 49 closed out, a net change of -49 holders.
  • The largest Omega Therapeutics, Inc. Common Stock seller in Q1 2025 was Flagship Pioneering, an estimated $21.8M sold.

Based on aggregated 13F filings for Q1 2025.